Isomorphic Labs · Series B
London-based AI drug-design company spun out of Google DeepMind to reimagine the entire drug
Amount
$2.1B
Round
Series B
Valuation
—
Announced
May 2024
Notes
auto-discovered via firecrawl
London-based AI drug-design company spun out of Google DeepMind to reimagine the entire drug
Amount
$2.1B
Round
Series B
Valuation
—
Announced
May 2024
auto-discovered via firecrawl